A Phase I/III Randomized, Double-blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment

Project: Research

Project Details

StatusActive
Effective start/end date23/08/23 → 22/08/25

Keywords

  • clinical trial
  • COVID-19
  • PreP